MacroGenics
MGNX
#8685
Rank
NZ$0.43 B
Marketcap
NZ$6.82
Share price
-2.30%
Change (1 day)
131.05%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2026 (TTM): NZ-$2.62

According to MacroGenics's latest financial reports the company's current EPS (TTM) is NZ-$2.59. In 2025 the company made an earnings per share (EPS) of NZ-$1.99 a decrease over its 2024 EPS that were of NZ-$1.81.

EPS history for MacroGenics from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$2.6231.6%
2025NZ-$1.9910.28%
2024NZ-$1.81613.33%
2023NZ-$0.25-92.31%
2022NZ-$3.29-42.14%
2021NZ-$5.6936.44%
2020NZ-$4.17-21.84%
2019NZ-$5.34-24.58%
2018NZ-$7.08675.93%
2017NZ-$0.91-68.05%
2016NZ-$2.86168.25%
2015NZ-$1.06-55%
2014NZ-$2.373400%
2013NZ-$0.06758-108.68%
2012NZ$0.7824.49%
2011NZ$0.63

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.21-185.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$47.69-1,944.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.47-1,046.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$12.54-584.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.04-333.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$6.01-332.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ-$3.87 49.67%๐Ÿ‡บ๐Ÿ‡ธ USA